Johnson & Johnson (JNJ) Operating Margin: 27.17%
Is Johnson & Johnson’s operating margin high or low?
Johnson & Johnson's operating margin of 27.17% is in line with its 5-year average of 26.06%, near the high end of its 5-year range (23.89%–27.49%).
The operating margin for Johnson & Johnson (JNJ) is 27.17% as of Tuesday, June 9, 2026. It is above its 12-month average by 4.28% (26.05%).
JNJ Operating Margin Chart
JNJ Average Operating Margin Chart
JNJ Current vs Average Operating Margin Chart
JNJ Operating Margin Metrics
OPERATING MARGIN
27.17%
OPERATING MARGIN AVG TTM
26.05%
OPERATING MARGIN AVG 3Y
26.47%
OPERATING MARGIN AVG 5Y
26.06%
OPERATING MARGIN AVG 10Y
26.16%
OPERATING MARGIN AVG 15Y
26.24%
OPERATING MARGIN AVG 20Y
26.10%
CURRENT VS TTM AVG
+4.28%
CURRENT VS 3Y AVG
+2.65%
CURRENT VS 5Y AVG
+4.26%
CURRENT VS 10Y AVG
+3.86%
CURRENT VS 15Y AVG
+3.56%
CURRENT VS 20Y AVG
+4.10%
JNJ Competitors' Operating Margin
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | — | 27.17% | 26.05% | 26.47% | 26.06% |
| Pfizer Inc. (PFE) | $146.48B | 24.67% | 25.29% | 24.23% | 24.05% |
| Merck & Co., Inc. (MRK) | $295.39B | 36.17% | 33.84% | 25.86% | 23.98% |
| AbbVie Inc. (ABBV) | $398.27B | 32.85% | 24.54% | 25.94% | 26.75% |
| Eli Lilly and Company (LLY) | $1.08T | 45.56% | 42.21% | 36.59% | 33.96% |
| Bristol-Myers Squibb Company (BMY) | $115.34B | 26.34% | 23.17% | 21.31% | 19.39% |
Operating Efficiency
Gross Margin
72.8%
Operating Margin
27.2%
Johnson & Johnson Operating Margin Formula & Definition
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Johnson & Johnson Operating Margin FAQ
- What is the operating margin for Johnson & Johnson (JNJ)?
- The operating margin for JNJ stock is 27.17%.
- Is Johnson & Johnson's operating margin high or low?
- Johnson & Johnson's operating margin of 27.17% is in line with its 5-year average of 26.06%, near the high end of its 5-year range (23.89%–27.49%).
- What is the TTM average operating margin for Johnson & Johnson (JNJ)?
- The TTM average operating margin for JNJ stock is 26.05%.
- What is the 3Y average operating margin for Johnson & Johnson (JNJ)?
- The 3Y average operating margin for JNJ stock is 26.47%.
- What is the 5Y average operating margin for Johnson & Johnson (JNJ)?
- The 5Y average operating margin for JNJ stock is 26.06%.
- What is the 10Y average operating margin for Johnson & Johnson (JNJ)?
- The 10Y average operating margin for JNJ stock is 26.16%.
- What is the 15Y average operating margin for Johnson & Johnson (JNJ)?
- The 15Y average operating margin for JNJ stock is 26.24%.
- What is the 20Y average operating margin for Johnson & Johnson (JNJ)?
- The 20Y average operating margin for JNJ stock is 26.10%.
Johnson & Johnson Operating Margin History
| DATE | OPERATING MARGIN |
|---|---|
| 2025-12-28 | 27.17% |
| 2024-12-29 | 24.94% |
| 2023-12-31 | 27.49% |
| 2023-01-01 | 26.27% |
| 2022-01-02 | 26.60% |
| 2021-01-03 | 23.89% |
| 2019-12-31 | 25.55% |
| 2018-12-31 | 25.96% |
| 2017-12-31 | 24.72% |
| 2016-12-31 | 29.06% |
| 2015-12-31 | 26.10% |
| 2014-12-31 | 28.44% |
| 2013-12-31 | 26.58% |
| 2012-12-31 | 25.34% |
| 2011-12-31 | 24.84% |
| 2010-12-31 | 26.84% |
| 2009-12-31 | 26.92% |
| 2008-12-31 | 25.36% |
| 2007-12-31 | 24.90% |
| 2006-12-31 | 25.71% |
| 2005-12-31 | 25.40% |
| 2004-12-31 | 26.10% |
| 2003-12-31 | 25.97% |
| 2002-12-31 | 26.66% |
| 2001-12-31 | 24.40% |
| 2000-12-31 | 22.68% |
| 1999-12-31 | 21.37% |
| 1998-12-31 | 20.95% |
| 1997-12-31 | 20.43% |
| 1996-12-31 | 19.90% |
Related Metrics
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato